OCC 2.70% 36.0¢ orthocell limited

OCC Trading, page-1604

  1. 4,627 Posts.
    lightbulb Created with Sketch. 859
    Agree mostly but PNV showed yesterday that punters will reward steady gains in sales when it's demonstrated that it can be achieved on a self-funded basis.

    Now you, me and a bunch of other folk on here obviously hope and/or expect that Striate sales are going to ramp-up sufficiently (and with sufficient margin) to substantially bridge that quarterly hole in cash flow.

    These guys have been pretty good but when you've had companies like MSB in the same sector repeatedly bleed their retail investors dry while management has done quite well financially themselves achieving two fifths of not much for the company then investors have a right to be cautious.

    If and when OCC sufficiently demonstrate a path to cash neutrality (and/or other positive news) then I'll expect a substantial rerate but until then I reckon we're stuck below 50c. The Striate royalty payment was great but it was a one off.
    Last edited by optimistus: 23/01/24
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
(20min delay)
Last
36.0¢
Change
-0.010(2.70%)
Mkt cap ! $75.35M
Open High Low Value Volume
37.0¢ 37.0¢ 36.0¢ $59.55K 163.3K

Buyers (Bids)

No. Vol. Price($)
1 41666 36.0¢
 

Sellers (Offers)

Price($) Vol. No.
36.5¢ 101155 1
View Market Depth
Last trade - 15.37pm 25/06/2024 (20 minute delay) ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.